Enfermedad de Charcot de pie y tobillo en pacientes con diabetes mellitus: análisis de las causas de re consultas en una unidad de pie diabético hospitalaria / Charcot´s disease of the foot and ankle in diabetic patients: analysis of the reasons for re admission at the hospital diabetic unity / Neuroartropatía de Charcot do pé e tornozelo em pacientes com diabetes mellitus: análise das causas das novas consultas em uma unidade de pés diabéticos do hospital

La neuroartropatia de Charcot es una complicación devastadora para los pacientes diabéticos, generando deformidades osteoarticulares con riesgo de ulceración, infección y amputación de miembros inferiores. El objetivo fue analizar en una población de pacientes diabéticos con secuela de neuroartropatía de Charcot, el motivo de re consulta y los tratamientos a los que fueron sometidos. El mismo se realizó en forma retrospectiva mediante observación de historias clínicas y estudios radiológicos de 22 pacientes tratados entre 2014 y 2018 en el Hospital Policial de Montevideo - Uruguay, con un tiempo de evolución mínimo de un año al momento de la revisión. Se contó con la aprobación del Comité de Ética de dicho hospital habiéndose completado un formulario con datos demográficos, tratamiento inicial, causas de las re consultas y tratamientos secundarios. Si bien al inicio de la enfermedad se siguieron los protocolos de tratamiento con alto nivel de recomendación, se observaron en las re consultas elevados porcentajes de re ulceración y necesidad de cirugías complementarias (59%). Se vinculan los resultados a la falta de categorización de paciente de riesgo para lograr seguimiento y captación precoz. El categorizar al paciente de riesgo permite establecer estrategias de educación y de tratamientos tendientes a disminuir porcentajes de nuevas lesiones que lleven a la necesidad de tratamientos secundarios o amputaciones.

One of the most devastating complications within diabetic patients is Diabetic Charcot neuroarthropathy. It can lead to osteoarticular deformities, with risk of ulceration, infection or even lower limb amputation. In this paper, a population of diabetic patients with Charcot neuroarthropathy sequelae was studied. Data was analyzed on the reasons for the patients re consultation, the treatments they were subjected to and the obtained results. The study was conducted retrospectively by the examination of medical records from 22 patients that were treated between 2014 and 2018, with a follow-up of at least a year, at the Hospital Policial in Montevideo, Uruguay. Furthermore, it had the hospital's Ethics Committee approval. The data analysis was conducted by the completion of a form including demographic data, initial treatment, reasons for re consultation and secondary treatments. According to the findings, even though highly recommended protocols were followed at the onset of the disease, high percentage of ulceration and complementary surgeries were observed (59%) within the patient's data. The results are linked to the lack of risk patient´s categorization in order to achieve early uptake. Categorizing the patient at risk makes it possible to establish health education and treatment strategies aimed at reducing percentages of new injuries that lead to the need for secondary treatments or amputations.

A neuroartropatia de Charcot é uma complicação devastadora para os pacientes com diabetes, gerando deformidades osteoarticulares residuais com risco de úlceras, infecção e amputação maior dos membros inferiores. O objetivo foi analisar em uma população de pacientes diabéticos com sequelas da neuroartropatia de Charcot, o motivo da nova consulta e os tratamentos a que foram submetidos, bem como os resultados obtidos. Foi realizado retrospectivamente por meio de observação de histórias clinicas e estudos radiológicos de 22 pacientes atendidos no periodo de 2014 a 2018 no Hospital da Polícia de Montevidéu - Uruguai, com tempo de evolução mínimo de um ano na época da revisão. Foi aprovado pelo Comité de Ética do referido hospital, tendo sido preenchido um formulário com dados demográficos, tratamento inicial, causas das novas consultas e tratamentos secundários. Embora protocolos de tratamento com alto nível de recomendação tenham sido seguidos no início da doença, elevados percentuais de re ulcerações e cirurgias complementares (59%) foram observados nas novas consultas. Os resultados estão ligados à falta de categorização dos pacientes de risco para obter captação precoces A categorização do paciente de risco permite estabelecer estratégias de educação e tratamento com o objetivo de reduzir os percentuais de novas lesões que levam à necessidade de tratamentos secundários ou amputações.

Effectiveness of lower extremity Dellon triple nerve decompression in treatment of early-stage diabetic Charcot foot / 中国修复重建外科杂志

Objective: To study the effectivenss of lower extremity Dellon triple nerve decompression in the treatment of early-stage diabetic Charcot foot. Methods: The clinical data of 24 patients with Eichenholtz stage 0-1 diabetic Charcot foot who were admitted between September 2017 and February 2019 were retrospectively analyzed. Among them, 14 cases were treated with lower extremity Dellon triple nerve decompression (treatment group), and 10 cases were treated with conservative treatment such as immobilization the affected limbs and nutritional nerve drugs (control group). There was no significant difference between the two groups ( P>0.05) in gender, age, diabetes duration, diabetic foot duration, Eichenholtz stage, and the blood glucose level, bone mineral density (T value), nerve conduction velocity, and two-point discrimination before treatment. Before treatment and at 6 months after treatment, bone mineral density (T value) was measured by dual energy X-ray absorptiometry to evaluate the improvement of osteoporosis. The electromyogram of the lower limbs was used to detect the conduction velocity of the common peroneal nerve, deep peroneal nerve, and tibial nerve, and to evaluate the recovery of nerve function. The two-point discrimination in plantar region was used to evaluate the recovery of skin sensation. Results: Both groups were followed up 6-12 months, with an average of 6.5 months. In the treatment group, 3 patients showed numbness around the incisions, all recovered after 12 months, without affecting the prognosis; all the incisions healed by first intention, and there was no complication such as incision infection, nonunion, or vascular and nerve injury. At 6 months after treatment, there was no significant difference in nerve conduction velocity, bone mineral density (T value), and two-point discrimination when compared with the values before treatment ( P>0.05) in the control group; but the above indicators in the treatment group were significantly improved when compared with preoperative ones, and were all significantly better than those in control group ( P<0.05). Conclusion: Lower extremity Dellon triple nerve decompression can improve the symptoms of Eichenholtz stage 0-1 diabetes Charcot foot, and has the advantages of less trauma, faster recovery, and fewer complications.

Evaluación del uso del clavo centromedular retrógrado bloqueado para artrodesis de tobillo en pacientes con neuroartropatía de Charcot / Retrograde intramedullary nail fixation for Charcot neuroarthropathy

Resumen: La artropatía de Charcot se define como un padecimiento articular degenerativo, crónico y progresivo que se caracteriza por lesiones óseas destructivas sin presencia de infección. La neuropatía está asociada directamente con la diabetes mellitus tipo 1 y 2. La cirugía está indicada cuando existe compromiso de partes blandas, inestabilidad de las articulaciones del tobillo y pie, cuando se desarrollan úlceras recurrentes o no es posible adecuar el tobillo o el pie a un calzado normal o en los pacientes que presentan deformidad severa, úlceras o dolor crónico y limitación para realizar las actividades de la vida diaria. El presente es un trabajo observacional, prospectivo, transversal y descriptivo de pacientes con diagnóstico de neuroartropatía de Charcot tipo 3a de Brodsky tratados quirúrgicamente mediante artrodesis de tobillo con clavo centromedular retrógrado bloqueado, del 1o de Enero de 2010 al 31 de Agosto de 2015. Se analizaron 16 pacientes. En el preoperatorio la media de la escala de AOFAS fue de 35.0 ± 5.2 puntos. Un seguimiento postoperatorio de cuatro años con un mínimo de siete meses. En el postoperatorio la escala de AOFAS mostró un incremento de 40 puntos hacia la mejoría (p = 0.0001). La técnica revisada logra la estabilización ósea, resultando en un pie con apoyo plantígrado que disminuye la aparición de úlceras crónicas y mejora el desarrollo en las actividades de la vida cotidiana.

Abstract: Charcot arthropathy is defined as an articular degenerative, chronic, progressive disease that affects one or more peripheral joints, develops as a result of a failure in the normal sensory perception (pain and proprioception) in the innervation of joints located in the foot and ankle, is characterized by destructive bone lesions without the presence of infection. Neuropathy is directly associated with diabetes mellitus type 1 and 2. Surgery is indicated when there is severe involvement of soft tissue, foot joints are unstable, at the presence of chronic or recurrent ulcers or when the foot and ankle can not fit to a normal shoe, and had limitation to perform activities of daily living. Material and methods: Design: observational, prospective, transversal, descriptive. Sample: patients diagnosed with Charcot neuropathy type 3a of Brodsky. Surgically treated by ankle arthrodesis with an intramedullary blocked nail, from January 2010 to August 2015. Results: 16 patients were analyzed. Preoperative AOFAS score was 35.0 ± 5.2 points. Postoperative follow-up period of 4 years to 7 months. Postoperative AOFAS scale showed an improvement of 40 points (p = 0.0001). Conclusions: The proposed treatment allows bone stabilization, resulting in a full foot plantar support and decreases the occurrence of chronic ulcers that are difficult to treat, and is an alternative method that avoids lead to amputation.

Reconstrucción quirúrgica en paciente con pie de Charcot / Surgical Reconstruction in Patient with Charcot Foot

Se presentó paciente masculino de procedencia rural, de la raza blanca de 51 años de edad con antecedentes de diabetes mellitus tipo 2, medicado con metformina seis tabletas por día en las principales comidas. Remitido en julio de 2014, del Hospital Provincial de Santi Spiritus por presentar un pie de Charcot. La reconstrucción quirúrgica del pie de Charcot es a menudo difícil por la presencia de infecciones, isquemia y neuropatía. En muchos casos la amputación es lo indicado. El paciente era portador de una neuroartropatía con inestabilidad de su pie. Dada la extensa destrucción de los huesos del pie y su marcada osteoporosis la amputación fue sugerida, procedimiento rechazado por el paciente y prefirió explorar otras opciones de salvataje de su extremidad. En la actualidad el pie de Charcot es sensible al tratamiento traumatológico, en este caso se requirió una estrategia de salvataje de su extremidad con fusión del meso con el retropié utilizando tornillos de esponjosa de 4 mm, asociado con terapia con antibióticos que resultó en la obtención de un pie plantígrado y funcional.

A 51 white male patient with a history of type 2 Diabetes Mellitus was treated with metformin (six tablets a day in main meals). Surgical reconstruction of Charcot arthropathy of the foot is often difficult, because of bone loss, deformities, vasculopathy, and the presence of active infection. In such situations, an amputation would usually be the surgical option. Due to the extensive bone destruction because of osteoporosis presence, an amputation was suggested. The patient did not agree with an amputation and wanted to explore options for limb recover. A case of limb-threatening Charcot deformity with instability was presented. A limb salvage strategy with hind foot fusion combined with an antibiotic for reconstruction of the mid and hind foot was used, resulting in a plantigrade, painless, and functional foot.

Identification of high-risk groups of charcot foot in the people with diabetic foot neuropathic ulcerations / 中国综合临床

Objective To identify high?risk groups of Charcot foot( CN) in the people with diabetic foot neuropathic ulcerations( NU) . Methods Twenty cases patients with CN who were diagnosed in General Hospital of the Chinese People Air Force from June 2008 to June 2013 and 58 patients with diabetic neuropathic ulcer who were hospitalized from January 2010 to December 2011 and followed up until June 2014 without foot deform?ity were retrospectively analyzed. All patient's general condition, examination and laboratory results, diabetic chronic complications,complication,diabetes distribution of foot ulcers,and plain features. Results There were no statistically significant differences in terms of patients' average age, sex ratio, proportion of smokers, BMI, HbA1c,blood lipid,dorsalis pedis artery diameter and diabetic nephropathy (Ⅲ?Ⅳperiod) ,chronic kidney dis?ease stage 3 above,proliferation diabetic retinal pathological changes,the prevalence of coronary heart disease between the two groups(P>0. 05). Compared with NU group,patients with single high proportion(40. 00%(8/20) vs. 10. 34%(6/58)),Short duration of diabetes((12. 37±5. 64) years vs. (14. 27±8. 04) years),Feet long numbness(6(5,9) years vs. 4(2,20) years),low rate of hardening of the arteries narrow(ABI<0. 9)( 0 ( 0/20) vs. 39. 66%( 13/58) ) ,high recurrent diabetic foot ulcer prevalence( 70. 00%( 14/20) vs. 25. 86%( 15/58)),more patients with diabetes mellitus autonomic neuropathy(75. 00%(15/20) vs. 39. 66%(23/58)),less combined with hypertension ( 25. 00%( 5/20 ) vs. 58. 62%( 34/58 ) ) , the differences were significant ( t orχ2=6. 981,2. 259,4. 068,3. 887,12. 405,7. 436,6. 724;P<0. 05) . Diabetic foot wound distribution on mesopodi?um of CN group and NU group was 36. 84%(7/19),6. 90%(4/58) respectively,the difference was significant (χ2=11. 443,P=0. 003) . Diabetic foot amputation rate( Wanger 4,5 grade) of CN group and NU group was 44. 44%(4/9),6. 90%(2/29) respectively,the difference was significant(χ2=4. 732,P=0. 020). Conclusion The characteristics of high?risk groups of diabetics Charcot foot in the people with diabetic foot neuropathic ulcerations are middle aged,no foot of ischemia,combine the diabetic autonomic neuropathy and the feet always with recurrent ulcers.

Diabetes mellitus de tipo 1 y pie de charcot en el tercer estadio de Eichenholtz / Type 1 diabetes mellitus and Charcot neuroarthropathy at Eichenholtz's stage III

El propósito de este trabajo es describir el caso de una paciente con diabetes mellitus de tipo1 con pie de Charcot, el primero registrado en el Hospital General Universitario "Guillermo Domínguez López" en Las Tunas, 2013. Se trata de una paciente blanca, de 21 años de edad que llegó al Servicio de Angiología y Cirugía Vascular del citado hospital por presentar una artropatía neuropática de Charcot, en el estadio tres de Eichenholtz, en el curso de una diabetes mellitus de tipo 1, con 12 años de evolución y un mal control metabólico, complicación rara e infrecuente en nuestro medio. Se realizó interrogatorio, examen físico, y estudios analíticos e imagenológicos y se decidió su ingreso. En el primer ingreso se logró la compensación de la diabetes, de la hipertensión arterial, y que el pie disminuyera de volumen. Después presentó múltiples ingresos por uro-sepsis y descontrol metabólico, hasta que fue incorporada a la hemodiálisis por insuficiencia renal y en su posterior evolución comenzó a presentar pericarditis urémica con fallo cardiaco y fallecimiento posterior. Ante la presencia de un aumento de volumen, edema del pie, lesión articular por la que no se siente dolor, deformidad e inestabilidad articular con neuropatía sensitiva-motora en extremidades inferiores, se debe pensar en una neuroartropatía de Charcot y así evitar su evolución hacia la última etapa de Eichenholtz. Este caso es de gran interés para la atención médica de los pacientes diabéticos por todas las especialidades médicas y dirigido especialmente a la atención primaria de salud(AU)

The objective of this paper was to describe the case of a female who suffered type 1 diabetes mellitus and Charcot neuroarthropathy, the first of this type managed in "Guillermo Dominguez Lopez" general university hospital in Las Tunas province in 2013. This patient was a 21 years-old Caucasian woman, who went to the angiology and vascular surgery service of the hospital, because she presented with Charcot neuropathic arthropathy at Eichenholtz´s stage III in the course of type 1 of diabetes mellitus of 12 years of evolution and inadequate metabolic control. This was a rare and uncommon complication in our setting. The patient was questioned about her symptoms and physically examined, then subjected to analytical and imaging studies; it was finally decided to admit her to hospital. In her first period of hospitalization, diabetes and blood hypertension were duly controlled and the foot swelling was reduced. After several admissions to hospital due to urinary sepsis and lack of metabolic control, she was accepted in the hemodyalisis treatment program due to renal failure, but later on, she began suffering uremic pericarditis, heart failure and finally died. In the face of raised volume, foot edema, painless joint injure, joint deformity and instability with sensory-motor neuropathy in lower limbs, one should think of Charcot neuroarthropathy and thus prevent the evolution into the last Eichenholtz´s stage. This is a case of great interest for the medical care of diabetic patients by all medical specialties and mainly aimed at the primary health care(AU)

Risk factors for Charcot foot

Objective Diabetes mellitus is the main cause of Charcot neuroarthropathy and is clinically classified as follows: Charcot foot, acute Charcot foot (ACF) when there is inflammation, and inactive Charcot foot when inflammatory signs are absent. The aim of this study was to identify the risk factors for ACF in patients with type 2 diabetes mellitus.Materials and methods A matched case-control study was conducted to assess the factors associated with acute Charcot foot from February 2000 until September 2012. Four controls for each case were selected 47 cases of ACF and 188 controls without ACF were included. Cases and controls were matched by year of initialization of treatment. Conditional logistic regression was used to estimate matched odds ratios (ORs) and 95% confidence intervals (95% CIs).Results In multivariate analysis, patients having less than 55 years of age (adjusted OR = 4.10, 95% CI = 1.69 – 9.94), literate education age (adjusted OR = 3.73, 95% CI = 1.40 – 9.92), living alone (adjusted OR = 5.84, 95% CI = 1.49 – 22.86), previous ulceration (adjusted OR = 4.84, 95% CI = 1.62 – 14.51) were at increased risk of ACF. However, peripheral arterial disease (adjusted OR = 0.16, 95% CI = 0.05 – 0.52) of 6.25 (1.92 – 20.0) was a protective factor.Discussion The results suggest that PCA in type 2 diabetes primarily affects patients under 55 who live alone, are literate, and have a prior history of ulcers, and that peripheral arterial disease is a protective factor. Arch Endocrinol Metab. 2015;59(3):226-30.